article thumbnail

The Importance of International R&D Collaborations in Generic Drug Development

Drug Patent Watch

In the realm of generic drug development, international research collaborations are emerging as a game-changer. By pooling resources, expertise, and knowledge, researchers from around the globe can accelerate the discovery of life-saving treatments and make them more accessible to those who need them most.

article thumbnail

New cell therapy model accelerates cancer treatment development

Drug Target Review

We believed the missing piece was essentially an internal biotech at MD Anderson – one that could collaborate with researchers to industrialise their processes for cell therapies. While therapies like CAR-T have shown great success in hematologic malignancies, solid tumours remain a challenging area for current treatments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia

National Drug & Alcohol Research Centre Blog

Kendal Chidwick NDARC’s Kendal Chidwick discusses the findings from a recently published study that examined how patterns of opioid agonist treatment medicines have changed over the past decade. Other changes around this time aimed at improving treatment accessibility included increased use of take-home doses and telehealth appointments.

Treatment 133
article thumbnail

Organoids: the versatile platform for discovery and regeneration

Drug Target Review

8 With the widespread use of induced pluripotent stem cells (iPSCs), organoids can now be generated from the skin or blood cells of both healthy volunteers and disease patients, opening the door to studying various diseases and creating individually customised potential treatments. Organoids in cancer research. Nat Rev Cancer. Cell Stem Cell.

Treatment 106
article thumbnail

New treatment option for metastatic colorectal cancer prolongs survival

SCIENMAG: Medicine & Health

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options. Credit: Vanderbilt University Medical Center A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

article thumbnail

New antiviral materials made from sugar have been developed to destroy viruses on contact and may help in the fight against viral outbreaks.

Drug Discovery Today

This new development from a collaborative team of international scientists shows promise for the treatment of herpes simplex (cold sore virus), respiratory syncytial virus, hepatitis C, HIV, and Zika virus to name a few.

Virus 170
article thumbnail

Cellular atlas built to guide precision treatment of rheumatoid arthritis

Broad Institute

While RA therapies targeted to specific inflammatory pathways have emerged, only some patients’ symptoms improve with treatment, emphasizing the need for multiple treatment approaches tailored to different disease subtypes. They also found that patients’ CTAPs were dynamic and could change over time in response to treatment.